Ghrelin - A Possible Opportunity to Improve Appetite

Phase 3

Completed

• Conditions: Cancer
• Interventions: Drug: Ghrelin

• Registration Number: NCT00681486
• Lead Sponsor: Göteborg University

Brief Summary

The study is designed to evaluate whether ghrelin treatment can improve appetite in weight losing cancer patients.

Detailed Description

Randomized study with follow up evaluations each month until preterminal state. Cancer patients will be randomised to either high dose or low dose of active treatment given as daily injection.

Study Timeline

• Study Start: 2003-10
• Study First Submitted: 2008-05-19
• Study First Submitted QC: 2008-05-20
• Study First Posted: 2008-05-21
• Primary Completion: 2008-06
• Study Completion: 2008-07
• Status Verified: 2009-08
• Last Update Submitted: 2009-08-20
• Last Update Posted: 2009-08-21

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

• Weight loss

Exclusion Criteria

• Diabetes

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
A, 1	Ghrelin	Ghrelin
A, 2	Ghrelin	Ghrelin.

Primary Outcome Measures

Name	Time	Method
Food intake	June 2008

Trial Locations

Locations (1)

Department of surgery, Sahlgrenska University Hospital; 🇸🇪 Göteborg, Sweden